Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

por Kühnast, Susan, van der Tuin, Sam J.L., van der Hoorn, José W.A., van Klinken, Jan B., Simic, Branko, Pieterman, Elsbet, Havekes, Louis M., Landmesser, Ulf, Lüscher, Thomas F., Willems van Dijk, Ko, Rensen, Patrick C.N., Jukema, J. Wouter, Princen, Hans M.G.
Publicado 2015

Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets

por van der Tuin, Sam J. L., Li, Zhuang, Berbée, Jimmy F. P., Verkouter, Inge, Ringnalda, Linda E., Neele, Annette E., van Klinken, Jan B., Rensen, Sander S., Fu, Jingyuan, de Winther, Menno P. J., Groen, Albert K., Rensen, Patrick C. N., Willems van Dijk, Ko, Wang, Yanan
Publicado 2018